Testing effectiveness (Phase 2)Study completedNCT02270944
What this trial is testing
Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
Who this might be right for
Infections, StreptococcalStreptococcal Infections
GlaxoSmithKline 1,053